How many insider trades does FilingIQ track for SIGA?

FilingIQ tracks 243 Form 4 insider transactions for SIGA (SIGA TECHNOLOGIES INC), covering filings from May 18, 2015 onwards. 0 of those are dated within the last 90 days.

Are SIGA insiders net buyers or net sellers?

Across the full Form 4 history for SIGA, 11 transactions (5%) were open-market purchases and 9 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SIGA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is SIGA in?

SIGA TECHNOLOGIES INC (SIGA) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $489.46M.

SIGA insider trading

NasdaqGM Healthcare

SIGA TECHNOLOGIES INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades

243

Last 90 days

Buys / sells

5% / 4%

Market cap

$489.46M

About SIGA TECHNOLOGIES INC

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Company website: www.siga.com

SIGA insider activity at a glance

FilingIQ tracks 243 insider transactions for SIGA in filings since May 18, 2015. The most recent transaction is dated Jun 9, 2026.

Across the full history, 11 open-market purchases and 9 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SIGA insider trades is 58.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SIGA trades on FilingIQ Raw filings on SEC EDGAR

Latest SIGA Form 4 filings

Marshall Joseph W III

ADM Jun 10, 2026

KEANE JOHN M

ADM Jun 10, 2026

Ford Harold Eugene Jr.

Miller Larry R. General Counsel

FM Mar 26, 2026

Luckshire Daniel J Executive VP & CFO

AFM Mar 17, 2026

Hruby Dennis E EVP & Chief Scientific Officer

AFM Mar 17, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for SIGA?: FilingIQ tracks 243 Form 4 insider transactions for SIGA (SIGA TECHNOLOGIES INC), covering filings from May 18, 2015 onwards. 0 of those are dated within the last 90 days.
Are SIGA insiders net buyers or net sellers?: Across the full Form 4 history for SIGA, 11 transactions (5%) were open-market purchases and 9 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SIGA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is SIGA in?: SIGA TECHNOLOGIES INC (SIGA) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $489.46M.

Methodology & sources

Every SIGA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.